These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14221633)

  • 1. [ANTIGENIC, TOXIC AND PROTECTIVE PROPERTIES OF THE CELLULAR COMPONENTS OF BORDETELLA PERTUSSIS].
    DEMINA AA; STANISLAVSKII ES; LARINA LI
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Apr; 41():17-22. PubMed ID: 14221633
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE PATHOGENESIS OF INTRAPERITONEAL INFECTION WITH BORDETELLA PERTUSSIS IN MICE. 9. STUDIES ON THE ROLE AND IMMUNOGENIC NATURE OF PURIFIED AGGLUTINOGENS AND TOXIN FRACTIONS IN INTRAPERITONEAL INFECTION].
    ISHII T
    Nihon Saikingaku Zasshi; 1963 Dec; 18():458-64. PubMed ID: 14151195
    [No Abstract]   [Full Text] [Related]  

  • 3. THE NEUTRALIZATION OF B. PERTUSSIS TOXIN IN A TISSUE CULTURE.
    STRIZOVA V; TRLIFAJOVA J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():428-32. PubMed ID: 14238941
    [No Abstract]   [Full Text] [Related]  

  • 4. [RESEARCH ON ANAPHYLATOXIN-TACHYPHYLAXIS AND ON ITS SIGNIFICANCE FOR THE DURATION OF THE TRUE ANAPHYLACTIC REACTION].
    FRIEDBERG KD; ENGELHARDT G; MEINEKE F
    Int Arch Allergy Appl Immunol; 1964; 25():154-81. PubMed ID: 14219621
    [No Abstract]   [Full Text] [Related]  

  • 5. [MECHANISM OF THE POTENTIATION OF TOXOID ANTIGENIC ACTION BY MEANS OF TOXIN. I. SPECIFICITY OF THE POTENTIATING ACTION OF TOXIN].
    MORGUNOV IN; IAGUD SL; BARSHTEIN IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Apr; 41():40-5. PubMed ID: 14224707
    [No Abstract]   [Full Text] [Related]  

  • 6. MEDIATORS OF EXPERIMENTAL NEPHRITIS.
    DASGUPTA R; DHAR HL; GUPTA DN; SANYAL RK
    Indian J Med Res; 1964 May; 52():496-501. PubMed ID: 14175607
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the toxins of Bordetella pertussis. 8. Pathohistologic studies on all organs of mice inoculated with pertussis toxin].
    KUROKOCHI T
    Nihon Saikingaku Zasshi; 1961 Dec; 16():1046-52. PubMed ID: 14460789
    [No Abstract]   [Full Text] [Related]  

  • 8. [EXPERIMENTAL STUDY OF COMBINED IMMUNIZATION AGAINST STAPHYLOCOCCAL INFECTIONS, TETANUS, TYPHOID AND PARATYPHOID B. II. RESISTANCE OF IMMUNIZED ANIMALS TO CORRESPONDING BACTERIAL CULTURES AND THEIR TOXINS].
    LEPIK BK
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jun; 41():125-30. PubMed ID: 14225811
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigens of Bordetella pertussis. II. Purification of heat-labile toxin.
    BANERJEA A; MUNOZ J
    J Bacteriol; 1962 Aug; 84(2):269-74. PubMed ID: 13864610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHOLERA TOXINS: QUANTITATION OF THE FROG SKIN REACTION AND ITS RELATION TO EXPERIMENTAL ENTERIC TOXICITY.
    BURROWS W; MUSTEIKIS GM; OZA NB; DUTTA NK
    J Infect Dis; 1965 Feb; 115():1-8. PubMed ID: 14258474
    [No Abstract]   [Full Text] [Related]  

  • 11. CHEMICAL STUDIES ON CELLULAR COMPONENTS OF BORDETELLA PERTUSSIS. III. ISOLATION OF HIGHLY POTENT TOXIN FROM BORDETELLA PERTUSSIS.
    ONOUE K; KITAGAWA M; YAMAMURA Y
    J Bacteriol; 1963 Oct; 86(4):648-55. PubMed ID: 14066457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STUDY OF THE ANTIGENIC STRUCTURE OF COXIELLA BURNETI. 3. PYROGENIC EFFECT OF PHASE I ANTIGEN IN EXPERIMENTAL GUINEA PIGS.
    BREZINA R; SCHRAMEK S; URVOELGYI J
    Acta Virol; 1965 Mar; 9():180-5. PubMed ID: 14303934
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES ON PERTUSSIS TOXIN.
    LIN TM
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1963 Mar; 62():226-31. PubMed ID: 14060999
    [No Abstract]   [Full Text] [Related]  

  • 14. BIOCHEMICAL AND ANTIGENIC PROPERTIES OF A PURIFIED NEUROTOXIN OF VIPERA PALESTINAE VENOM.
    MOROZ-PERLMUTTER C; GOLDBLUM N; DE VRIES A
    J Immunol; 1965 Jan; 94():164-71. PubMed ID: 14253515
    [No Abstract]   [Full Text] [Related]  

  • 15. [Purification of the agglutinogen, the toxin, and the infection-preventing antigen, cell-body constituents of Bordetella pertussis].
    KASUGA T; NAKASE Y
    Nisshin Igaku Jpn J Med Prog; 1962 Apr; 49():283-6. PubMed ID: 14454203
    [No Abstract]   [Full Text] [Related]  

  • 16. [RESEARCH ON SAPONIN, AN ADJUVANT SUBSTANCE WHICH STIMULATES IMMUNITY. I].
    RICHOU R; JENSEN R; BELIN C
    Rev Immunol Ther Antimicrob; 1964; 28():49-62. PubMed ID: 14187805
    [No Abstract]   [Full Text] [Related]  

  • 17. PHARMACOLOGIC STUDIES OF A TOXIC CELLULAR COMPONENT OF LISTERIA MONOCYTOGENES.
    MCILWAIN P; EVELETH DF; DOUBLY JA
    Am J Vet Res; 1964 May; 25():774-81. PubMed ID: 14141521
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of the reaction of the living body to pertussis vaccine, with special reference to electromyographic experiments with the intercostal muscles. II. Electromyogram of the intercostal muscles by inoculation with Hemophilus pertussis type I and Hemophilus pertussis toxin after Hemophilus pertussis vaccination].
    KURODA I
    Paediatr Jpn; 1961 Jun; 65():643-8. PubMed ID: 13755302
    [No Abstract]   [Full Text] [Related]  

  • 19. [ALTERATION OF BACTERIAL TOXINS BY THE CONSTITUENTS OF CHAMOMILE AND HORSERADISH. 3].
    KIENHOLZ M
    Arzneimittelforschung; 1963 Nov; 13():980-6. PubMed ID: 14210438
    [No Abstract]   [Full Text] [Related]  

  • 20. THE SYNTHESIS AND PHARMACOLOGICAL ACTION OF TREMETONE.
    BOWNE DM; DEGRAW JI; SHAH VR; BONNER WA
    J Med Chem; 1963 May; 6():315-9. PubMed ID: 14185993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.